ISRCTN13047154进行中（未招募）未知
Imaging Fibroblast Activation Protein (FAP) in non-small cell lung cancer using PET scan and correlation with outcomes of usual therapy.
niversity of Edinburgh0 个研究点目标入组 15 人开始时间: 2022年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Capacity to provide informed consent
- •2. Confirmed lung cancer for which surgical resection is being planned (Cohort 1)
- •3. Confirmed lung cancer (cohort 2) planned for systemic oncological treatment
- •4. Treatment naïve patients =50 years
- •5. Thoracic CT scan taken within the previous 12 weeks
- •6. ECOG performance status 0-2
排除标准
- •1. Inability or unwilling to give informed consent.
- •2. Unable to tolerate the supine position
- •3. Impaired renal function with eGFR of <30 mL/min/1.73m²
- •4. Severe or significant comorbidity that prevents systemic oncological therapy or performance status 3 or 4
- •5. Women who are pregnant or breastfeeding
研究者
相似试验
招募中
不适用
Fibroblast Activating Protein Inhibitor PET Imaging in Lupus NephritisLupus NephritisNCT05845151Ruijin Hospital30
招募中
不适用
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint InhibitorsNon Small Cell Lung CancerNCT06107608Jules Bordet Institute58
招募中
Unknown
Pilot study of fibroblast activation factor expression in recurrent/progressive pancreatic cancer and mesothelioma using [68Ga]Ga-Fibroblast Activation Protein Inhibitor (FAPI) -46 PET imaging.pancreatic cancerACTRN12623001078640Sir Charles Gairdner and Osborne Park Health Care Group30
招募中
1 期
A Study of 177Lu-FAP-2286 in Advanced Solid TumorsSolid TumorNCT04939610Novartis Pharmaceuticals222
招募中
不适用
FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patientsCrohn's diseaseulcerative colitisInflammatory bowel disease10017969NL-OMON53519Amsterdam UMC20